# Pharma and Healthcare mutual funds compared

Source page: https://www.rudowealth.com/mutual-funds/category/pharma-and-healthcare-funds

Pharma and healthcare funds put at least 80% of their assets in pharmaceutical, hospital and other healthcare companies. (SEBI categorisation of mutual fund schemes, 6 October 2017, as amended.)

All 19 pharma and healthcare funds, Direct plan, Growth option, NAV as of 2026-10-07. Every figure is worked out from each fund's own NAV.

Category averages: 3-year return +21.6% a year, 5-year return +14.8% a year (both annualised), volatility over 3 years 16.0%, expense ratio 1.04%.

| Rank | Fund | 1Y | 3Y (annualised) | 5Y (annualised) | Volatility 3Y | Worst fall 5Y | Expense ratio | Fund size |
|---|---|---|---|---|---|---|---|---|
| 1 | [SBI Healthcare Opportunities Fund - Direct Plan -Growth](https://www.rudowealth.com/mutual-funds/sbi-healthcare-opportunities-fund-direct-plan-growth) | +18.9% | +23.1% | +17.9% | 14.6% | -17.4% | 1.04% | ₹5,796 Cr |
| 2 | [ICICI Prudential Healthcare Fund - Direct Plan - Cumulative Option](https://www.rudowealth.com/mutual-funds/icici-prudential-pharma-healthcare-and-diagnostics-p-h-d-fund-direct-plan-cumulative-option) | +6.8% | +21.6% | +15.7% | 16.2% | -17.3% | 1.31% | ₹6,996 Cr |
| 3 | [DSP Healthcare Fund - Direct Plan - Growth](https://www.rudowealth.com/mutual-funds/dsp-healthcare-fund-direct-plan-growth) | +16.0% | +21.2% | +15.5% | 14.9% | -20.5% | 0.73% | ₹3,835 Cr |
| 4 | [UTI Healthcare Fund - Direct Plan - Growth Option](https://www.rudowealth.com/mutual-funds/uti-healthcare-fund-direct-plan-growth-option) | +15.6% | +23.0% | +15.3% | 16.0% | -20.3% | 1.26% | ₹1,444 Cr |
| 5 | [Mirae Asset Healthcare Fund Direct Growth](https://www.rudowealth.com/mutual-funds/mirae-asset-healthcare-fund-direct-growth) | +18.6% | +22.3% | +15.2% | 16.2% | -18.5% | 0.61% | ₹3,555 Cr |
| 6 | [Tata India Pharma & Healthcare Fund-Direct Plan-Growth](https://www.rudowealth.com/mutual-funds/tata-india-pharma-healthcare-fund-direct-plan-growth) | +6.4% | +18.7% | +14.0% | 16.6% | -16.8% | 1.00% | ₹1,565 Cr |
| 7 | [Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth](https://www.rudowealth.com/mutual-funds/aditya-birla-sun-life-pharma-and-healthcare-fund-direct-growth) | +15.4% | +20.3% | +13.9% | 15.4% | -19.5% | 1.02% | ₹1,103 Cr |
| 8 | [Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option](https://www.rudowealth.com/mutual-funds/nippon-india-pharma-fund-direct-plan-growth-plan-growth-option) | +10.7% | +17.9% | +13.4% | 14.9% | -18.7% | 0.99% | ₹9,479 Cr |
| 9 | [LIC MF Healthcare Fund-Direct Plan-Growth](https://www.rudowealth.com/mutual-funds/lic-mf-healthcare-fund-direct-plan-growth) | +12.4% | +21.4% | +12.0% | 16.2% | -21.3% | 1.42% | ₹103 Cr |
| 10 | [HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan](https://www.rudowealth.com/mutual-funds/hdfc-pharma-and-healthcare-fund-growth-option-direct-plan) | +25.3% | +30.0% | N/A | 16.1% | N/A | 1.08% | ₹3,311 Cr |
| 11 | [Quant Healthcare Fund - Growth Option - Direct Plan](https://www.rudowealth.com/mutual-funds/quant-healthcare-fund-growth-option-direct-plan) | +17.7% | +20.4% | N/A | 18.2% | N/A | 1.49% | ₹428 Cr |
| 12 | [ITI Pharma and Healthcare Fund - Direct Plan - Growth Option](https://www.rudowealth.com/mutual-funds/iti-pharma-and-healthcare-fund-direct-plan-growth-option) | +10.9% | +19.3% | N/A | 16.6% | N/A | 0.92% | ₹276 Cr |
| 13 | [Kotak Healthcare Fund - Direct Plan - Growth Option](https://www.rudowealth.com/mutual-funds/kotak-healthcare-fund-direct-plan-growth-option) | +28.1% | N/A | N/A | 16.2% | N/A | 1.09% | ₹768 Cr |
| 14 | [PGIM India Healthcare Fund - Direct Plan - Growth Option](https://www.rudowealth.com/mutual-funds/pgim-india-healthcare-fund-direct-plan-growth-option) | +23.2% | N/A | N/A | N/A | N/A | 0.93% | ₹125 Cr |
| 15 | [WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth](https://www.rudowealth.com/mutual-funds/whiteoak-capital-pharma-and-heathcare-fund-direct-plan-growth) | +20.9% | N/A | N/A | N/A | N/A | 1.13% | ₹902 Cr |
| 16 | [Bajaj Finserv Healthcare Fund - Direct - Growth](https://www.rudowealth.com/mutual-funds/bajaj-finserv-healthcare-fund-direct-growth) | +19.1% | N/A | N/A | N/A | N/A | 0.90% | ₹406 Cr |
| 17 | [Baroda BNP Paribas Health and Wellness Fund Direct Growth](https://www.rudowealth.com/mutual-funds/baroda-bnp-paribas-health-and-wellness-fund-direct-growth) | +9.9% | N/A | N/A | N/A | N/A | 1.56% | ₹507 Cr |
| 18 | [Bandhan Healthcare Fund - Direct Plan - Growth](https://www.rudowealth.com/mutual-funds/bandhan-healthcare-fund-direct-plan-growth) | N/A | N/A | N/A | N/A | N/A | 1.22% | ₹332 Cr |
| 19 | [Invesco India Pharma and Healthcare Fund - Direct Plan - Growth](https://www.rudowealth.com/mutual-funds/invesco-india-pharma-and-healthcare-fund-direct-plan-growth) | N/A | N/A | N/A | N/A | N/A | 0.00% | ₹0 Cr |

Ordered by 5-year annualised return, highest first; funds younger than 5 years follow by 3-year, then 1-year return. Volatility is the annualised standard deviation of monthly returns. Worst fall is the largest drop from a peak in the last 5 years. We do not label any fund as the best.

Investing from the UAE: NRIs can generally invest once KYC is complete, paying from an NRE or NRO bank account. Some fund houses do not accept residents of the United States or Canada. The UAE does not levy personal income tax, and the India UAE tax treaty may affect how gains are treated, so confirm your own position with a tax adviser.

---
RuDo Wealth is a fee-only cross-border advisory operating through two separate companies. India: RuDo Wealth Investment Advisory, SEBI Registered Investment Adviser, registration INA000019503. UAE: RuDo Digital Wealth, FSRA Financial Services Permission 220155, Category 3C (Retail), ADGM. The entity permitted to serve you depends on your country of residence.

General information, not a recommendation to buy or sell any fund. Past performance does not indicate future returns.